1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Moderna, Inc.
  6. Notizie
  7. Altre lingue
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Rapporto
Tempo differito Nasdaq  -  20/05 22:00:00
136.25 USD   -4.97%
20/05INTESA SANPAOLO: apre domani nuovo museo delle Gallerie d'Italia a Napoli
DJ
19/05BIOTECH: Keller (Bb Biotech), continua a crescere nonostante incertezza
DJ
19/05Moderna chiede l'approvazione di Swissmedic per il vaccino COVID-19 nei bambini dai sei mesi ai cinque anni di età
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settoreAnalisi MarketScreener
Notizie in altre lingue su MODERNA, INC.
19/05EU health regulator backs using AstraZeneca COVID shot as booster
19/05CORONA-BLOG/EMA akzeptiert Zulassungsantrag für Valneva-Impfstoffkandidat
19/05Moderna Seeks Swissmedic Nod For COVID-19 Shot In Children Aged Six Months To Five year..
18/05Bund will weiteren Corona-Impfstoff für den Herbst beschaffen
18/05As COVID cases rise, U.S. health officials mull widening additional booster eligibility
18/05CORONA-BLOG/Bundesregierung will vierte Corona-Impfung für alle ermöglichen
18/05Moderna, International AIDS Vaccine Initiative to Start Volunteer Screening for Phase 1..
18/05Bereits 100 000 überlagerte Impfdosen in Hamburg vernichtet
18/05BOLSA DE MADRIRD: Powell no rompió el ambiente
18/05From storage to transport, hurdles to getting COVID vaccine to N.Koreans
17/05MODERNA: présente des avancées dans la recherche
17/05TRANSCRIPT: Moderna, Inc. - Special Call
17/05FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
17/05AstraZeneca refuerza sus terapias contra el COVID con la compra de RQ Bio
16/05Valneva-Aktie bricht ein - EU will Covid-19-Vakzin-Kontrakt kündigen
16/05CORONAVIRUS: préavis de rupture du contrat européen avec Valneva
13/05MODERNA, INC. Change in Directors or Principal Officers, Financial Statements and Exhi..
13/05BOURSE ZURICH: retour dans le vert pour la dernière séance de la semaine
13/05SECTOR UPDATE: Health Care Stocks Gain Premarket Friday
13/05KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
13/05Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
13/05Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
13/05BOURSE ZURICH: le SMI consolide ses gains à l'approche de la mi-journée
13/05N.Korea gets offers of aid to fight COVID as it lacks vaccines
13/05Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
13/05Swissmedic lässt Moderna-Impfstoff für Kinder zwischen 6 und 11 Jahren zu
12/05MARKETSCREENER’S WORLD PRESS REVIEW: May 12, 2022
12/05GENEURO: augmentation de capital de 7,7 millions d'euros
12/05LE NOUVEAU AIRBNB, LA VICTOIRE DE KO: la revue de presse du jeudi 12 mai
12/05Valores destacados al cierre del mercado norteamericano
12/05Rusia sanciona las filiales de Gazprom en Europa y EEUU y al gestor del gasoducto polac..
12/05WALL STREET: séance plombée par les chiffres de l'inflation
12/05Moderna CFO exits firm a day after taking charge as probe launched
12/05Moderna completes FDA submission for use of COVID shot in adolescents, kids
11/05Moderna, Inc. Fires Jorge Gomez as CFO
11/05Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
11/05Moderna feuert Finanzchef - 700 000 Dollar für zwei Tage
11/05CFO Moderna vertrekt al weer
11/05MODERNA: départ du CFO récemment nommé
11/05Les valeurs à suivre aujourd'hui à Wall Street Mercredi 11 mai 2022
11/05MODERNA: le directeur financier part déjà
11/05Moderna Ousts New Finance Chief Amid Probe at Dentsply
11/05Moderna Says Recently Named CFO Jorge Gomez Departs; David Meline Continues as CFO
11/05MODERNA, INC.: El nuevo director financiero de Moderna se marcha tan pronto como llega
11/05Aussitôt arrivé, le nouveau directeur financier de Moderna s'en va
11/05Moderna CFO, Jorge Gomez, Resigns Effective Immediately
11/05Moderna CFO exits a day after taking charge as former employer launches probe
11/05Moderna's new CFO Jorge Gomez steps down
11/05MODERNA, INC.: Change in Directors or Principal Officers (form 8-K)
11/05Rovi mantiene previsiones para 2022 tras duplicar beneficios en el primer trimestre
10/05What you need to know about the coronavirus right now
10/05Novavax shares slide 20% on COVID vaccine demand uncertainty
09/05Novavax 2022 COVID vaccine deliveries off to slow start, shares drop
09/05Novavax posts drop in COVID research funding, slow start to 2022 vaccine delivery
09/05Los fabricantes de vacunas de COVID pasan a centranse en los refuerzos
09/05COVID vaccine makers shift focus to boosters
06/05Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from var..
06/05Les valeurs à suivre aujourd'hui à Wall Street - Vendredi 6 mai 2022
06/05JOHNSON & JOHNSON: la FDA limite l'utilisation du vaccin
06/05VACCINATION COVID-19: 5713 effets indésirables graves
06/05Les Etats-unis limitent l'accès au vaccin anti-Covid de Johnson & Johnson
06/05USA schränken Zugang zu Johnson & Johnson-Impfstoff ein
05/05U.S. limits use of J&J's COVID vaccine on blood clot risks
05/05FDA restricts J&J's COVID-19 vaccine due to blood clot risk
05/05Los bancos centrales intensifican la lucha contra la inflación
05/05WDH: EMA rechnet mit Zulassung von Omikron-Impstoffen bis September
05/05CORONA-BLOG/EMA prüft Zulassung von Moderna-Impfstoff für Kleinkinder
05/05COVID-19: l'EMA examine le vaccin Moderna pour les moins de cinq ans
05/05Moderna rides high on Covid-19 vaccine sales with $6bn revenue
04/05INSIDER SELL: Moderna
04/05Wall Street fête la décision d'une Fed moins sévère que redouté
04/05MÄRKTE USA/Aktien- und Rentenrally dank US-Notenbankchef Powell
04/05MODERNA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
04/05Wall Street hoger gesloten
04/05Moderna Q1 profit triples on robust COVID vaccine sales
1  2  3  4  5  6  7  8  9  10Pross.